Ignite Creation Date:
2024-05-06 @ 3:14 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04562129
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2020-09-18
Brief Title:
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-18
First Submit QC Date:
September 18 2020
Study First Post Date:
2020-09-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-03
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL